Biodesix (BDSX) Free Cash Flow (2019 - 2026)

Biodesix (BDSX) has 8 years of Free Cash Flow data on file, last reported at -$10.2 million in Q1 2026.

• Quarterly Free Cash Flow fell 19.35% year-over-year to -$10.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$25.2 million (up 43.92% YoY) and the FY2025 annual result came in at -$23.5 million, up 54.64% from the prior year.
• Free Cash Flow fell to -$10.2 million in Q1 2026, from $692000.0 in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $7.7 million in Q4 2023 to a low of -$20.5 million in Q2 2024.
• A 5-year average of -$9.2 million and a median of -$9.7 million in 2023 frame the typical range for Free Cash Flow.
• Annual changes were most pronounced in 2022 — Free Cash Flow slumped 795.13% — and 2023, when it jumped 154.57%.
• Tracing BDSX's Free Cash Flow over 5 years: stood at -$14.1 million in 2022, then jumped by 154.57% to $7.7 million in 2023, then sank by 164.22% to -$4.9 million in 2024, then surged by 114.02% to $692000.0 in 2025, then slumped by 1581.07% to -$10.2 million in 2026.
• The last three Free Cash Flow figures came in at -$10.2 million (Q1 2026), $692000.0 (Q4 2025), and -$8.9 million (Q3 2025), per Business Quant data.